| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunitybio, Inc. (IBRX) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 17 sells. IBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 29.82M | $249.75M | - | |
| CEO | 548.2K | $4.59M | - | |
| CFO | 322.8K | $2.70M | - | |
| Dir | 162.8K | $1.36M | - | |
| Dir | 162.8K | $1.36M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2020 | Simon Barry J.79 | See Remarks | Sale+OE | 9 | $13.00 | $117.00 | - | |
| Jun 29, 2020 | Soon-Shiong Patrick | Chairman And CEO | Buy | 3,710,000 | $12.12 | $44,965,200.00 | +18.5% | |
| Jun 23, 2020 | Simon Barry J.79 | See Remarks | Sale+OE | 200,041 | $10.56 | $2,112,950.19 | -1.2% | |
| May 27, 2020 | Simon Barry J.79 | See Remarks | Sell | 75,000 | $7.56 | $567,337.50 | -2.3% | |
| May 21, 2020 | Simon Barry J.79 | See Remarks | Sell | 36,932 | $5.52 | $203,698.45 | -1.1% | |
| May 11, 2020 | Simon Barry J.79 | See Remarks | Sell | 28,068 | $5.50 | $154,508.73 | -0.8% | |
| Dec 16, 2019 | Thomas John C | Director | Sell | 30,000 | $2.87 | $86,000.00 | -2.9% | |
| Dec 12, 2019 | Thomas John C | Director | Sell | 10,000 | $1.99 | $19,918.00 | -2.7% | |
| Sep 9, 2019 | Thomas John C | Director | Sell | 24,000 | $1.24 | $29,789.64 | -2.1% | |
| Nov 29, 2018 | Gorlin Steve | Director | Sell | 138,349 | $1.65 | $228,275.85 | -100% |